Molecular Docking Study of Gingkgo Biloba Compounds As Potential Inhibitors of SARS-CoV-2. SCRIPTA SCORE Sci Med J. 2022, 4 (1), 30-43. https://doi.org/10.32734/scripta.v4i1.8399.